Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)

https://www.soho2019.com/

 

Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)
J

New Frontline Regimens in Peripheral T-Cell Lymphoma: Brentuximab Vedotin+CHP, Lenalidomide, Alemtuzumab and Romidepsin for CHOP/CHOP-like + Disease

By Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019) FEATURING Julie M. Vose
By Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019) FEATURING Julie M. Vose
188 views
October 18, 2019
Comments 0
Login to view comments. Click here to Login

Featured Video

18:30
Pfizer Hematology

Expert Case Review: A Treatment Option for Adult Patients With Stage…

Feat. A. Whiteley

Featured Video

16:51
Incyte

Effects of PV Treatment on White Blood Cell Count and Thrombotic Risk

Feat. C. Harrison
T-cell Lymphoma
15:48

New Frontline Regimens in Peripheral T-Cell Lymphoma: Brentuximab Ve…

Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)

J. Vose

188 views
16:59

Novel Approaches in Peripheral T-Cell Lymphoma Treatment: Challenges…

Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)

O. O’Connor

38 views
09:35

New Insights into the Molecular Pathogenesis of Peripheral T-Cell Ly…

Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)

P. Gaulard

32 views
07:09

Preliminary Results of Phase II Trial of Brentuximab Vedotin and Len…

Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)

B. William

31 views